373 related articles for article (PubMed ID: 16841141)
21. [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression.
Rajendran JG; Wilson DC; Conrad EU; Peterson LM; Bruckner JD; Rasey JS; Chin LK; Hofstrand PD; Grierson JR; Eary JF; Krohn KA
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):695-704. PubMed ID: 12632200
[TBL] [Abstract][Full Text] [Related]
22. Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images.
Mönnich D; Troost EG; Kaanders JH; Oyen WJ; Alber M; Zips D; Thorwarth D
Acta Oncol; 2013 Oct; 52(7):1308-13. PubMed ID: 23984808
[TBL] [Abstract][Full Text] [Related]
23. Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.
Cherk MH; Foo SS; Poon AM; Knight SR; Murone C; Papenfuss AT; Sachinidis JI; Saunder TH; O'Keefe GJ; Scott AM
J Nucl Med; 2006 Dec; 47(12):1921-6. PubMed ID: 17138734
[TBL] [Abstract][Full Text] [Related]
24. Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma.
Zegers CM; van Elmpt W; Hoebers FJ; Troost EG; Öllers MC; Mottaghy FM; Lambin P
Acta Oncol; 2015; 54(9):1378-84. PubMed ID: 26213313
[TBL] [Abstract][Full Text] [Related]
25. Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging.
Löck S; Perrin R; Seidlitz A; Bandurska-Luque A; Zschaeck S; Zöphel K; Krause M; Steinbach J; Kotzerke J; Zips D; Troost EGC; Baumann M
Radiother Oncol; 2017 Sep; 124(3):533-540. PubMed ID: 28843726
[TBL] [Abstract][Full Text] [Related]
26. Assessment of tumour hypoxia, proliferation and glucose metabolism in head and neck cancer before and during treatment.
Kazmierska J; Cholewinski W; Piotrowski T; Sowinska A; Bak B; Cegła P; Malicki J
Br J Radiol; 2020 Feb; 93(1106):20180781. PubMed ID: 31860336
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of [
Jiang H; Zhang R; Jiang H; Zhang M; Guo W; Feng G; Pan W; Xu H; Wang S
Nucl Med Biol; 2019; 72-73():36-44. PubMed ID: 31330410
[TBL] [Abstract][Full Text] [Related]
28. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
[TBL] [Abstract][Full Text] [Related]
30. Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging.
Mönnich D; Troost EG; Kaanders JH; Oyen WJ; Alber M; Thorwarth D
Phys Med Biol; 2012 Mar; 57(6):1675-84. PubMed ID: 22398239
[TBL] [Abstract][Full Text] [Related]
31. Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling.
Bowen SR; van der Kogel AJ; Nordsmark M; Bentzen SM; Jeraj R
Nucl Med Biol; 2011 Aug; 38(6):771-80. PubMed ID: 21843774
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.
Rajendran JG; Mankoff DA; O'Sullivan F; Peterson LM; Schwartz DL; Conrad EU; Spence AM; Muzi M; Farwell DG; Krohn KA
Clin Cancer Res; 2004 Apr; 10(7):2245-52. PubMed ID: 15073099
[TBL] [Abstract][Full Text] [Related]
33. Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer.
Zschaeck S; Zöphel K; Seidlitz A; Zips D; Kotzerke J; Baumann M; Troost EGC; Löck S; Krause M
Radiother Oncol; 2021 Feb; 155():204-211. PubMed ID: 33252044
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of hypoxia and correlation with glycolytic metabolism and angiogenic biomarkers in metastatic colorectal carcinoma.
Lee ST; Muralidharan V; Tebbutt N; Wong P; Fang C; Liu Z; Gan H; Sachinidis J; Pathmaraj K; Christophi C; Scott AM
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1585-1592. PubMed ID: 33125527
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.
Grönroos TJ; Lehtiö K; Söderström KO; Kronqvist P; Laine J; Eskola O; Viljanen T; Grénman R; Solin O; Minn H
BMC Cancer; 2014 Nov; 14():876. PubMed ID: 25421331
[TBL] [Abstract][Full Text] [Related]
36. Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice.
Schütze C; Bergmann R; Brüchner K; Mosch B; Yaromina A; Zips D; Hessel F; Krause M; Thames H; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
Radiother Oncol; 2014 Apr; 111(1):81-7. PubMed ID: 24636842
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.
Jansen JF; Schöder H; Lee NY; Wang Y; Pfister DG; Fury MG; Stambuk HE; Humm JL; Koutcher JA; Shukla-Dave A
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1403-10. PubMed ID: 19906496
[TBL] [Abstract][Full Text] [Related]
38. Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.
Nehmeh SA; Lee NY; Schröder H; Squire O; Zanzonico PB; Erdi YE; Greco C; Mageras G; Pham HS; Larson SM; Ling CC; Humm JL
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):235-42. PubMed ID: 18086391
[TBL] [Abstract][Full Text] [Related]
39. Two or four hour [¹⁸F]FMISO-PET in HNSCC. When is the contrast best?
Abolmaali N; Haase R; Koch A; Zips D; Steinbach J; Baumann M; Kotzerke J; Zöphel K
Nuklearmedizin; 2011; 50(1):22-7. PubMed ID: 21165537
[TBL] [Abstract][Full Text] [Related]
40. Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
Thureau S; Chaumet-Riffaud P; Modzelewski R; Fernandez P; Tessonnier L; Vervueren L; Cachin F; Berriolo-Riedinger A; Olivier P; Kolesnikov-Gauthier H; Blagosklonov O; Bridji B; Devillers A; Collombier L; Courbon F; Gremillet E; Houzard C; Caignon JM; Roux J; Aide N; Brenot-Rossi I; Doyeux K; Dubray B; Vera P
J Nucl Med; 2013 Sep; 54(9):1543-50. PubMed ID: 23918733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
